Pharmasund Nordic ApS: Financial statements 2023
CVR: 41686669
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharmasund Nordic ApS (CVR 41686669) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK -77,235 compared with DKK 0 the year before. Equity in the 2023 report amounted to DKK -151,321.
- Profit/Loss
- DKK -77,235
- Equity
- DKK -151,321
- Total Assets
- DKK 584
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of September 22, 2023, Mette Lund Lavesen is registered as director of Pharmasund Nordic ApS.
As of September 21, 2023, Puyan Abedinpour Farahani has stepped down as director of Pharmasund Nordic ApS.
As of August 31, 2023, P8 Ventures ApS is registered as an owner of Pharmasund Nordic ApS with an ownership share of 33%.
As of August 31, 2023, IDAN Invest ApS is registered as an owner of Pharmasund Nordic ApS with an ownership share of 33%.
As of August 31, 2023, Hjerpsted Holding ApS is registered as an owner of Pharmasund Nordic ApS with an ownership share of 33%.
Pharmasund Nordic ApS has published its annual report for 2022. The net result was DKK 0.
About Pharmasund Nordic ApS
Pharmasund Nordic ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2020. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Ismail Nayef Ismail Khdeir. The company is owned by P8 Ventures ApS, IDAN Invest ApS and Hjerpsted Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 151,397 and a net result of DKK 113,664 compared with DKK 63,921 the year before. Equity in the 2025 report amounted to DKK 26,264.
